| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Total operating revenue | 386,381 | 386,390 | 407,519* | 345,253 |
| Medical expense | 300,377 | 336,024 | 437,531* | 369,789 |
| Premium deficiency reserve | -8,659 | -4,715 | 63,304* | -23,736 |
| Corporate, general and administrative expense | 32,393 | 25,543 | 38,160* | 22,139 |
| Sales and marketing expense | - | 227 | 315* | 251 |
| Depreciation and amortization | 21,044 | 21,074 | 20,989* | 21,033 |
| Impairment of assets held for sale | - | - | 0* | - |
| Total operating expense | 345,155 | 378,153 | 560,298* | 389,476 |
| Operating income (loss) | 41,226 | 8,237 | -152,779* | -44,223 |
| Interest expense, net | -7,862 | -16,766 | -9,147* | -20,527 |
| Mark-to-market of stock warrants and purchased put option | 16,366 | -330 | -8,657* | 2,540 |
| Gain (loss) on disposition of assets | - | - | -40* | - |
| Other | -82 | 242 | -1,048* | -2,160 |
| Total other expense | -24,310 | -16,194 | -1,579* | -25,227 |
| Income (loss) before income taxes | 16,916 | -7,957 | -154,359* | -69,450 |
| Income tax benefit (provision) | 1,265 | -10,997 | -963* | 11 |
| Net income (loss) | 15,651 | 3,040 | -153,396* | -69,461 |
| Less net income (loss) attributable to non-controlling interests | 8,207 | 1,817 | -83,372* | -37,874 |
| Net income (loss) attributable to controlling interest | 7,444 | 1,223 | -70,024 | -31,587 |
| Less cumulative preferred stock dividends | 9,570 | - | - | - |
| Net loss attributable to class a common stockholdersbasic | -2,126 | - | - | - |
| Basic EPS | -0.63 | 0.37 | -21.401 | -9.67 |
| Diluted EPS | -0.63 | 0.32 | -21.401 | -9.67 |
| Basic Average Shares | 3,362,000 | 3,288,000 | 3,272,000 | 3,268,000 |
| Diluted Average Shares | 3,362,000 | 8,417,000 | 3,272,000 | 3,268,000 |
P3 Health Partners Inc. (PIIIW)
P3 Health Partners Inc. (PIIIW)